Skip to main content
. Author manuscript; available in PMC: 2020 Dec 6.
Published in final edited form as: Circ Res. 2019 Oct 21;125(12):1055–1066. doi: 10.1161/CIRCRESAHA.119.315343

Figure 7. A20 in CD11c+ myeloid cells suppresses the hypertensive response via a T cell-dependent mechanism.

Figure 7.

(A) Mean arterial pressures measured by radio-telemetry in Rag1−/−mice (“Rag1−/−”, open circles) and Rag1−/− Cd11c-Cre+ A20flox/wt (“Rag1−/− DC ACT”, open squares) mice at baseline (“pre”) and during chronic Ang II infusion. Comparisons between the groups were performed using the two-way ANOVA. (B) Ratio of heart weight/body weight (mg/g) in the Rag1−/− and Rag1−/−DC ACT groups after 28 days of Ang II infusion. N=5–6 mice/group. Statistical significance was assessed using an unpaired Student’ t-test. Data are mean ± SE.